Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial
Titel:
Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial
Auteur:
Verschraegen, Claire Andric, Zoran Moiseenko, Fedor Makharadze, Tamta Shevnya, Sergii Oleksiienko, Alona YaƱez Ruiz, Eduardo Kim, SungHyun Ahn, KeumYoung Park, TaeHong Park, Sijin Ju, Hana Ohe, Yuichiro